Lenti-HBV (FLLTRILTI) TCR (Cysteine-modified)-VP(VP-TCR-C185)
The ready-to-use lentiviral particles of Lenti-HBV TCR (Cysteine-modified)-VP is packaged using 3rd generation of lentiviral packaging system, in which the gene of Human TCR will be driven by a CMV promotor. The target gene of TCR packaged in lentiviral particles could be used for high efficency tranduction of T cells and stably integrated expression.
Specifications
Type of Therapeutics
T cell receptor
Packaging System
Lentivirus
Targeting Diseases
Hepatitis B encoding at least one virus (HBV) and hepatocellular carcinoma (HCC)
Target
Introduction
epatitis B virus, abbreviated HBV, is a species of the genus Orthohepadnavirus, which is likewise a part of the Hepadnaviridae family of viruses. This virus causes the disease hepatitis B.
Alternative Names
HbsAg; HBV; Major surface antigen; TCR; T cell receptor; transgenic TCR; antigen-specific T cell receptors; Engineering T-cell receptors; recombinant t cell receptors; specific t cell receptor; modified t cell receptor; retroviral vector; Hepatitis B encoding at least one virus; HBV; hepatocellular carcinoma; HCC
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Related Products
Viral InfectionBlastomaOthers
Kits for CARs/TCRs Development